Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

FDA Alerts

FDA Alert
Woman taking a pill
FDA Alert
FDA Approves First Antipsychotic Medication Targeting Cholinergic Receptors for Patients With Schizophrenia
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
FDA Alert
Woman taking a pill
FDA Alert
FDA Approves First Antipsychotic Medication Targeting Cholinergic Receptors for Patients With Schizophrenia
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA ALERT
chemo
FDA ALERT
FDA Approves Pembrolizumab With Chemotherapy to Treat Primary Advance or Recurrent Endometrial Carcinoma in Patients
09/13/2024
Jessica Ganga
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
09/13/2024